Mark Kris

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Proceedings of the National Academy of Sciences of the United States of America · 2004 · 3,586 citations

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Case report · PLoS Medicine · 2005 · 2,891 citations